Thoratec Q2 Results Top Estimates

(RTTNews) - Thoratec Corp. (THOR), which has agreed to be acquired by St. Jude Medical (STJ) in a $3.4 billion cash deal, reported net income for the second quarter of $13.2 million or $0.24 per share, compared to $17.4 million or $0.30 per share for the year-ago quarter.

Excluding items, adjusted net income for the second quarter was $20.2 million or $0.37 per share, compared to $24.4 million or $0.43 per share in the prior year quarter.

Revenues for the second quarter rose 9% to $128.7 million from $118.1 million in the same quarter a year ago.

Analysts polled by Thomson Reuters expected the company to earn $0.28 per share on revenue of $118.00 million for the second quarter. Analysts' estimates typically exclude special items.